Business Wire

Regnology Acquires CG3-1 REGTECH LLC (CG3-1) to Expand North American Footprint

Share

Regnology, a leading software provider focused on regulatory reporting solutions, is pleased to announce the acquisition of CG3-1, a firm specializing in regulatory calculations for the USA broker-dealer market.

This strategic acquisition marks another milestone for Regnology as it further expands its footprint in the US with dedicated solutions for broker-dealers, covering regulatory capital, customer reserve, and portfolio margin requirements.

Established in 2018, CG3-1 has quickly become a household name for US broker-dealers looking to comply with regulatory requirements such as SEA 15c3-1, SEA 15c3-3, and FINRA Rule 4210.

The acquisition also presents substantial opportunities for CG3-1 to elevate its offerings. By leveraging Regnology’s extensive regulatory reporting capabilities, CG3-1 can expand its value chain end-to-end 15c3-1 and 15c3-3 reporting solutions, including automated data sourcing and last mile reporting such as the FOCUS report. This integration will also enable CG3-1 to deliver a more robust and seamless client experience through advanced orchestration and enhanced workflow efficiency.

Bobby Rahman, Regnology Head of M&A, commented: “We are excited to continue with our acquisition strategy and bring CG3-1 under the Regnology umbrella. This move further solidifies our market position, and we look forward to announcing further acquisitions soon as we strive to become the global reference for RegTech and SupTech.”

Rob Mackay, Regnology CEO, added: “We have long admired CG3-1’s leadership and the recognition they gained serving Tier 1 clients. Their calculation tools are recognized as the best available and will be a valuable addition to our product portfolio, enabling us to enhance our regulatory offerings for the North American market.”

Charles Greiner III, CG3-1 President, stated: “We are incredibly excited about this integration with Regnology. CG3-1 is the preeminent provider of regulatory capital (SEA Rule 15c3-1) technologies within the U.S. and working with Regnology will create significant value for existing CG3-1 clients, the moment this transaction closes. The Regnology platform will create enterprise grade business continuity and enterprise grade security around the CG3-1 product line. Moreover, the knowledge and expertise of the Regnology team which will empower CG3-1 t to expand our SEA Rule 15c3-1 and 15c3-3 offerings.”

The acquisition is effective immediately, and our teams will begin collaborating to integrate CG3-1’s solutions into Regnology’s offerings.

About CG3-1

CG3-1 is a leading provider of regulatory capital calculation solutions, specializing in SEA Rule 15c3-1 compliance for the US broker-dealer market. Our innovative software applications are designed to calculate net capital requirements, ensuring precise and efficient regulatory reporting. With a mission to become the go-to technology solution for financial operations professionals, CG3-1 combines deep industry expertise with cutting-edge technology to support broker-dealers, regulators, and auditors. Our commitment to excellence and customer satisfaction has established us as a trusted partner in the financial services industry.

Visit our website: www.cg3-1.com.

About Regnology

Regnology is a leading technology firm on a mission to bring safety and stability to the financial markets. With an exclusive focus on regulatory reporting and more than 35,000 financial institutions, 70 regulators, international organizations, and tax authorities relying on our solutions to process their regulatory reporting data, we are uniquely positioned to bring greater data quality, efficiency, and cost savings to all market participants. With over 900 employees in 16 countries and a unified data ingestion model powering our work, our clients can quickly implement and derive value from our solutions and easily keep pace with ongoing regulatory changes. Regnology was formed in 2021 when BearingPoint RegTech, a former business unit of BearingPoint Group, joined forces with Vizor Software, a global leader in regulatory and supervisory technology. The company is on a continued organic and external growth path, building up as one of the world's most recognized regulatory reporting powerhouses.

For more information about Regnology, connect with us on LinkedIn and X.

Visit our website: www.regnology.net.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241015760644/en/

Contacts

Mireille Adebiyi, Chief Marketing Officer
mireille.adebiyi@regnology.net

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kioxia Receives IEEE Corporate Innovation Award9.5.2025 10:00:00 EEST | Press release

Kioxia Corporation, a world leader in memory solutions, today announced that it has received the IEEE Corporate Innovation Award from the Institute of Electrical & Electronics Engineers (IEEE), the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity. This award recognizes Kioxia's outstanding contribution in the field of electrical and electronics engineering through its BiCS FLASH™ technology, a low-cost, high-capacity 3D flash memory innovation. The award ceremony was held on April 24 in Tokyo. The IEEE Corporate Innovation Award is a globally-recognized honor bestowed upon organizations that have developed innovative technologies, products or services that have made a substantial contribution to the advancement of electrical and electronics engineering. Since its inception in 1985, the award has been presented to leading electronics manufacturers and IT companies worldwide, and Kioxia is proud to be the seventh Japanese c

Suzano Reports Record First-Quarter Revenue9.5.2025 03:12:00 EEST | Press release

Suzano, the world’s largest pulp producer, announces its first quarter results for 2025 (1Q25) with record net revenue of R$11.6 billion, up 22% on the same quarter last year (1Q24). The result was driven by the exchange rates, increased pulp sales volumes from the new Ribas do Rio Pardo mill, higher paper volume and prices and the positive contribution from our paperboard mills recently acquired in the U.S. The record revenues occurred despite a series of planned downtimes in the quarter, including production lines of the Três Lagoas Unit, Mucuri Unit, and Aracruz Unit, and the Ribas do Rio Pardo Unit’s first scheduled maintenance downtime. Sales exceeded 3 million tonnes in the quarter, a rise of 12% compared to 1Q24, comprising 2.7 million tonnes of pulp and 390 thousand tonnes of paper, up 10% and 25%, respectively, on the same quarter last year. Adjusted EBITDA totaled R$4.9 billion, a 7% increase over 1Q24. Operating cash generation totaled R$2.6 billion, rising 5% on 1Q24. Net p

GC Aesthetics® Strengthens Board of Directors with Strategic Appointments8.5.2025 18:10:00 EEST | Press release

GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets is pleased to announce the appointment of Mr. Luigi Ferrari as Chairman of the Board (non-executive) and Mr. Patrick Lee as Board Director, reinforcing the company’s strategic direction and long-term growth plans. These appointments follow the renewed phase of partnership initiated in early 2024 with Hayfin Capital Management, a longstanding investor in GCA. This collaboration has brought fresh momentum to the company’s commitment to innovation, safety, and global expansion in aesthetic and reconstructive breast surgery. Luigi Ferrari, a seasoned executive and investor with a proven track record in the healthcare sector, brings deep leadership experience, commercial growth expertise and industry insight. From 2012 to 2022 he was CEO of Lima Corporate, a global medical device company in the joint replacement market, acquired then by Enovis Corp

PPG to invest $380 million to build new U.S. manufacturing facility in Shelby, N.C. for aerospace coatings and sealants8.5.2025 17:30:00 EEST | Press release

PPG (NYSE: PPG) today announced that it will invest $380 million to build a new aerospace coatings and sealants manufacturing facility in Shelby, N.C. Construction on the 62-acre site, which will initially include manufacturing and warehousing units, is set to commence in October 2025 and is expected to be completed in the first half of 2027. The 198,000-square-foot facility will enable the company to continue meeting the growing demands of the aerospace industry. It will employ more than 110 people and produce the full line of PPG’s aerospace coatings and sealants. The additional capacity of this new plant, combined with nearby transport links that improve supply chain and shipping logistics, will help improve service levels for customers. “PPG’s investment in this new manufacturing facility demonstrates the significant demand growth for our world-class technologies and our continued commitment to serving our aerospace customers,” said Tim Knavish, PPG chairman and chief executive off

WHOOP Unveils WHOOP® 5.0 and WHOOP® MG: Powerful New Devices with Breakthrough Health and Longevity Features8.5.2025 17:00:00 EEST | Press release

WHOOP, the human performance company, today introduces WHOOP 5.0 and WHOOP MG — two next-generation wearables designed to unlock a new approach to personal health and longevity. Paired with a redesigned WHOOP experience, the devices offer 14-day battery life in a sleeker, seven percent smaller form - and introduce category-defining features, including Healthspan with WHOOP Age, Heart Screener with on-demand ECG, Blood Pressure Insights, and more. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508546933/en/ WHOOP Unveils Next Generation WHOOP® 5.0 and WHOOP® MG These innovations arrive at a pivotal moment when ailing health systems cost more and deliver less. WHOOP is advancing a new solution and a better way - one that empowers people to connect their daily decisions to performance and health outcomes that can be measured and felt. While others track surface-level trends, WHOOP delivers longevity through depth — translati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye